When we think of disasters and disease outbreaks, there is a perception that these events are the great “equalizers”—striking at random and affecting affluent and marginalized communities alike. Nothing could be further from the truth, with the pandemic being the latest in a long line of evidence to the contrary.
As we have seen, poorer communities and communities of color are disproportionately affected by disasters and disease outbreaks. That’s due to the fact that when the systems that society has set up to ensure that people are safe and healthy are either non-existent or not strong enough, disasters will cause disproportionate harm to these communities.
The role of Healthcare Ready is to mitigate this preventable harm to our most vulnerable communities by building resilience and strengthening knowledge and empowerment where it is most needed.
A large part of that work is empowering communities with information—combating myths and misinformation by providing the resources residents need to make informed, positive decisions about their health and well-being—particularly during this pandemic.
This page provides those resources and important data to give context around how communities around the country are faring during the pandemic.
This project aims to shed light on the concerns and needs of communities in greatest need in order to address disparities in the response and outcomes of the pandemic. This page includes interactive datasets, data analyses, and community needs assessments with the results and recommendations from the IC3 project.
With the rollout of vaccines and removal of mask mandates in many states, the COVID-19 pandemic has evolved. Some individuals have developed immunity through antibodies or vaccination, but others are still vulnerable. Read this blog to learn more on what it means to be at-risk or vulnerable in the current state of the pandemic.
This infographic illustrates the disparate impact of the COVID-19 pandemic on Black and Latinx communities. Black and Latinx people are testing positive and dying at higher rates from coronavirus. Existing health and socioeconomic inequities have made the pandemic worse, and in turn, it is worsening those disparities in Black and Latinx communities.
The potential impact of monoclonal antibody treatments (mAbs) in the battle against COVID-19 is significant. mAbs have been shown to reduce the risk of hospitalizations or death by 70% in clinical trials. mAbs are an important tool for preventing the most severe outcomes for populations that have been hardest hit from the pandemic.